Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 250

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 250
---
 a description of the meeting at which the BLAC M&A Committee approved the draft LOI, which included discussions of conflicts of interest and a review of management of BLAC’s analyses of other target companies considered, see “— BLAC and OSR Holdings Discussions regarding Business Combination — June 18, 2023.”With respect to ratifying the non -disclosureagreement specifically, the BLAC M&A Committee considered the foregoing conflicts of interest and determined that ratifying the non -disclosureagreement did not present any additional risk to BLAC. Additionally, the BLAC M&A Committee, in ratifying actions taken by the BLAC Board prior to the BLAC M&A Committee’s formation, considered the foregoing conflicts of interest and determined that the BLAC Board had not taken any action other than entering into the non -disclosureagreement and holding routine discussions with management of OSR Holdings to discuss a potential business combination, which discussions were generally similar in nature to those that the BLAC Board was having with other target companies. Additionally, the individual directors who were appointed to the M&A Committee were generally involved in evaluating the target companies prior to the formation of the M&A Committee. In order to minimize the effects of any inherent conflicts of interest, Mr. Hwang left negotiations and discussions between BLAC and OSR Holdings largely in the hands of their respective management teams, boards of directors, and special committees, as applicable, and refrained from unilaterally making decisions regarding a business combination, or the terms thereof, without the input and approval of non -conflictedindividuals, including the BLAC M&A Committee. For the avoidance of doubt, any decisions that involved a material conflict of interest of Mr. Hwang were reviewed, considered, and resolved by the BLAC M&A Committee. The individuals listed below (along with their relevant expertise) were involved in the initial discussions between BLAC and OSR Holdings, and, as described above, were also involved in the joint review of certain other potential target companies. Dr. Steven G. Reed, former Director and BLAC M&A Committee Member, BLAC (business, healthcare industry, science, transaction) Dr. Radclyffe Roberts, former Director and BLAC M&A Committee Member, BLAC (business, healthcare industry, science) Mr. Jin Whan Park, Director and BLAC M&A Committee Member, BLAC (business, transaction) Mr. Kuk Hyoun Hwang, CEO and Director, BLAC and former CEO and current Chairman, OSR